ETIS PHARMA

ETIS PHARMA, a pharmacy, is registered at an address in Pont-à-Celles, Belgium. The company was founded in 2018, incorporated as a Besloten Vennootschap.

ETIS PHARMA is listed in Belgian Crossroads Bank for Enterprises (KBO) under registry number 0702914656 and VAT number BE0702914656. This profile consolidates Brønnøysund, Companies House Profile, Dk Cvr, KBO registry, KvK registry, NBB/CBSO annual accounts, official annual accounts, Staatsbladmonitor public filings, Titan Official Financials into one indexable company dossier.

Companies in this NACE 47730 band file annual accounts with NBB/CBSO.

Across the 2021-2025 window the gross-margin line has stayed broadly flat, moving from €255,048 to €259,449. EBITDA for 2025 comes in at €82,327. Because this line is gross margin from an abbreviated filing, not reported turnover, it is treated as public context rather than an automatic valuation base.

An indicative valuation band is available for ETIS PHARMA, indicative, given the source coverage available; the exact annual range stays behind the valuation chart until the visitor creates a free account. The chart below uses 8 historical valuation checkpoints to show the movement by fiscal year: a datapoint banks and acquirers explicitly ask for.

The most recent annual filing covers 2025.

The data on this page is a public, point-in-time projection of ETIS PHARMA's regulator-filed footprint, built to support indicative valuation bands, sellability context, and acquisition research.